AbbVie Inc. (NYSE:ABBV)

Medicine pills

SunTrust Has Large Cap Dividend Pharma Stocks to Buy Now

Despite the political uproar over some pharmaceutical pricing, the fact of the matter is that once the political cycle is over, it’s entirely possible a lot of the rhetoric and ...
Read Full Story »
white pills

Major Pharma Continues to See Rising Tide in Short Interest

The short interest data have been released for the September 15 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
investing

Jefferies Makes Huge New Stock Addition to Franchise Picks List

With earnings for the third quarter on deck, and the fourth quarter of 2016 almost underway, many of the top companies we follow on Wall Street are making some changes ...
Read Full Story »
money

How Much Will Consumers Save on New Humira Biosimilar?

Some interesting news that hit late last week may have been much larger news had not been going into the weekend. In a time when government wrangling about drug prices ...
Read Full Story »
Boeing 747

4 Jefferies Large Cap Franchise Picks That Also Pay Solid Dividends

With the third quarter all but over, and the market waiting this week to see if the Federal Reserve will increase rates (which most think they won’t), we are taking a ...
Read Full Story »
clinical trials

Jefferies Issues Top Pharma and Biohealth Stocks to Buy

Despite recent market headwinds and volatility, there are strong underlying fundamentals among the large cap pharmaceuticals that are continuing to drive them forward. One key analyst issued a few of its top picks ...
Read Full Story »
Prescription drugs

Major Pharma Continues to See Significant Drop in Short Interest

The short interest data have been released for the August 31 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
thumbs up and down

Top Analyst Upgrades and Downgrades: Apple, Callon Petroleum, Hewlett Packard Enterprise, Lululemon, Nike, Rio Tinto and More

Stocks were looking for direction on Thursday, and we are now over 50 days without a 1% move in either direction, despite being close to all-time highs. One thing that ...
Read Full Story »
Prescription drugs

Major Pharma Short Interest Faces Significant Drop

The short interest data have been released for the August 15 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
bull and bear

Credit Suisse Issues Top Pharma Picks in Bull/Bear Upside Analysis

It is sometimes hard to wonder about health care and pharmaceutical stocks during an election year. Still, with uncertainty can come opportunity. The team at Credit Suisse has issued its ...
Read Full Story »
Medicine pills

Major Pharma Short Interest Slides

The short interest data have been released for the July 29 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
investing

Jefferies Makes Another Big Summer Change to Its Franchise Picks List

With the second-quarter earnings reporting almost over, and the second half of 2016 well underway, many of the top firms we follow on Wall Street are making some changes to the ...
Read Full Story »
Prescription drugs

Jefferies Keeps Red-Hot Dividend Pharmaceutical Stock as Top Sector Pick

Health care has lagged the top sectors in the S&P 500 over the past year, but it is starting to catch up and some nice moves in the big pharmaceutical ...
Read Full Story »
Female patient on gurney

How AbbVie Won Big on Earnings

AbbVie Inc. (NYSE: ABBV) released its second-quarter earnings report before the markets opened on Friday. The company said that it had $1.26 in earnings per share (EPS) on $6.45 billion ...
Read Full Story »
gas pipeline

Jefferies Makes Key Changes to Top Energy Stocks in Franchise Picks Portfolio

With earnings season winding down, many of the top firms we cover on Wall Street are making some changes to their list of high conviction stocks that they present to ...
Read Full Story »